By Dave Ahearn Air Force Lt. Gen. Trey Obering, the Missile Defense Agency (MDA) director, said MDA is satisfied with the highly modified Boeing 747-400 jumbo-jet aircraft serving as the test bed for the Airborne Laser (ABL) missile defense system, and therefore would be unlikely to hold a competition for the ABL production-version aircraft. Asked whether MDA intends to put the ABL on some other plane when the program moves from development into production, Obering replied, "No, we're very satisfied…
Recommended
Trending
Congress Updates
Trump Wants Second Reconciliation Bill On His Desk By June 1
President Donald Trump on Wednesday called on Congress to pass and send a second reconciliation bill to his desk by June 1. The deadline follows congressional Republicans’ backing a pursuit […]
Upgrading Current GPS Ground System “Now a Viable Option,” As GPS OCX Problems Continue, Space Official Says
Upgrades to the GPS ground system–the Architecture Evolution Plan (AEP)–is an option under consideration by the Defense Department’s space acquisition chief, as problems continue in fielding the GPS Next Generation […]
Graham Says GOP To Move Ahead On Second Reconciliation Bill, With Defense Funds As Priority
Senate Budget Committee Chair Lindsey Graham (R-S.C.) said Wednesday, with the White House’s backing, his panel will move “expeditiously” on crafting a second reconciliation bill, citing priorities for defense and […]
Hegseth Acknowledges Potential $200 Billion Iran Supplemental Request, Final Figure ‘Could Move’
Defense Secretary Pete Hegseth on Thursday acknowledged the Pentagon could potentially ask Congress for $200 billion in supplemental funding to support the ongoing operation against Iran and replenish munitions used […]
Job Feed
-
Sr. Business Information Security Officer
Spanish and Portuguese - Bank of America - Chicago, IL -
Senior/ Principal Aerospace Engineer, AFSIM
Onsite - Sandia National Laboratories - Albuquerque, NM -
Cleared Principal Systems Engineer
Critical Infrastructure Systems, Onsite - Sandia National Laboratories - Albuquerque, NM -
Chief, Gastrointestinal (GI) Medical Oncology (3-309-1321)
University of Maryland, Baltimore - Baltimore, MD